Moreover, the observed discrepancy in ED degree category improvement according to IIEF-6 or PSV outcomes might be accounted by the absence of patients with baseline severe ED according to IIEF-6 score, as per exclusion criteria, along with the presence of a proportion of patients with baseline severe vasculogenic ED, which were included in the study based on their baseline mildmoderate or moderate ED at IIEF-6 score, as per inclusion criteria
The GLP-1RA needs to cross the Blood-Brain Barrier (BBB) to act on the brain and exert neuroprotective effects (12, 22)
2007;293(2):F5215 Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB
and 82103658 to Q.Z.), the Zhejiang Natural Science Foundation Key Project (LD22H160002 to D.X.), Zhejiang Natural Science Foundation Discovery Project (LQ22H160023 to Z.W.), Zhejiang Leading Innovation and Entrepreneurship Team (2022R01006 to X.Q.), Zhejiang University Research Fund (188020*194221901/029 to Z.L.), Postdoctoral Fellowship Program of Chinese Postdoctoral Science Foundation (GZC20241481 to Z.H.) and Shanghai Pujiang Program (2022PJD040 to Q.Z
Intended Use: Strictly for in-vitro laboratory research
Doctors must consider individual patient circumstances, local resources, and the specific guidance from their respective health systems
